We are live on
!
Find out more
Luther King Capital Management (LKCM) Portfolio holdings
AUM
$23.1B
1-Year Est. Return
21.31%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+21.31%
3 Year Est. Return
+69.23%
5 Year Est. Return
+91.95%
10 Year Est. Return
+415.11%
AUM
$13.7B
AUM Growth
+$630M
(+4.8%)
Cap. Flow
+$62.5M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
550
New
33
Increased
180
Reduced
167
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$29.9M |
| 2 |
Air Products & Chemicals
APD
|
+$21.3M |
| 3 |
Oracle
ORCL
|
+$20.8M |
| 4 |
Corteva
CTVA
|
+$19.4M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.2M |
| 2 |
AbbVie
ABBV
|
+$39M |
| 3 |
DuPont de Nemours
DD
|
+$35.8M |
| 4 |
Emerson Electric
EMR
|
+$18.3M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.5% |
| 2 | Healthcare | 16.29% |
| 3 | Financials | 14.99% |
| 4 | Industrials | 13.61% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kimberly-Clark
KMB
$36.5B
| $182M | 1.33% |
1,362,635
+7,739
| +0.6% | +$998K |
|
27
Alphabet (Google) Class A
GOOGL
$4.33T
| $168M | 1.23% |
3,110,560
-11,140
| -0.4% | -$645K |
|
28
EOG Resources
EOG
$70.7B
| $160M | 1.17% |
1,720,770
+192
| +0% | +$17.9K |
|
29
Kirby Corp
KEX
$6.93B
| $160M | 1.17% |
2,026,677
+685
| +0% | +$55K |
|
30
Distribution Solutions Group
DSGR
$1.61B
| $159M | 1.16% |
8,663,816
+75,414
| +0.9% | +$1.29M |
|
31
US Bancorp
USB
$99.6B
| $156M | 1.14% |
2,969,030
+1,158
| +0% | +$59.7K |
|
32
Merck
MRK
$318B
| $154M | 1.12% |
1,925,722
+72,980
| +4% | +$5.59M |
|
|
33
Alphabet (Google) Class C
GOOG
$4.32T
| $145M | 1.06% |
2,689,020
+38,900
| +1% | +$2.24M |
|
34
Martin Marietta Materials
MLM
$33B
| $145M | 1.06% |
628,368
-2,877
| -0.5% | -$623K |
|
35
Coca-Cola
KO
$375B
| $139M | 1.01% |
2,731,382
+21,261
| +0.8% | +$1.04M |
|
36
Walt Disney
DIS
$181B
| $138M | 1% |
986,330
+79,834
| +9% | +$10.6M |
|
37
Visa
V
$677B
| $135M | 0.98% |
776,788
+21,499
| +3% | +$3.52M |
|
38
Johnson & Johnson
JNJ
$625B
| $128M | 0.94% |
920,917
+67
| +0% | +$9.27K |
|
39
AT&T
T
$163B
| $126M | 0.92% |
4,986,564
+285,158
| +6% | +$6.84M |
|
40
Pfizer
PFE
$153B
| $126M | 0.92% |
3,059,058
-26,014
| -0.8% | -$1.03M |
|
41
Occidental Petroleum
OXY
$55.9B
| $124M | 0.9% |
2,457,660
+190,855
| +8% | +$10.7M |
|
42
Procter & Gamble
PG
$339B
| $121M | 0.88% |
1,103,818
+5,649
| +0.5% | +$602K |
|
43
Amgen
AMGN
$222B
| $116M | 0.84% |
627,312
-3,973
| -0.6% | -$711K |
|
44
Chevron
CVX
$366B
| $113M | 0.83% |
908,955
+31,295
| +4% | +$3.78M |
|
|
CTRA
45
DELISTED
Coterra Energy
CTRA
| $111M | 0.81% |
4,838,856
-319,541
| -6% | -$8.13M |
|
46
Cintas
CTAS
$81.3B
| $110M | 0.81% |
1,860,928
+187,520
| +11% | +$10.4M |
|
|
47
Emerson Electric
EMR
$88.3B
| $109M | 0.8% |
1,638,374
-273,871
| -14% | -$18.3M |
|
48
Colgate-Palmolive
CL
$74.4B
| $109M | 0.79% |
1,515,931
-7,473
| -0.5% | -$531K |
|
49
Mondelez International
MDLZ
$79.9B
| $105M | 0.77% |
1,948,817
+56,166
| +3% | +$2.92M |
|
50
Fortive
FTV
$18.6B
| $100M | 0.73% |
1,951,401
+45,947
| +2% | +$2.39M |
|
Similar funds
CAM
CHP
FAM
OAG
BA
Luther King Capital Management (LKCM)'s Q2 2019 Portfolio in Review
As of Q2 2019, Luther King Capital Management (LKCM) held 550 positions worth $13.7B, up 4.8% from $13.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Luther King Capital Management (LKCM)'s Q2 2019 filing shows 33 new, 180 increased, 167 reduced and 24 closed positions. Its largest new stake was Corteva: 722,792 shares worth $21.4M. The largest sale was Celgene Corp, an estimated $55.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Luther King Capital Management (LKCM)'s largest Q2 2019 buy was Corteva: 722,792 shares worth $21.4M.
- Luther King Capital Management (LKCM) added most to Charles River Laboratories in Q2 2019, an estimated $29.9M increase.
- Luther King Capital Management (LKCM)'s biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $55.2M.
- Luther King Capital Management (LKCM) fully exited Anadarko Petroleum in Q2 2019, selling an estimated $6.31M.
- Luther King Capital Management (LKCM)'s ten largest holdings make up 24% of its $13.7B portfolio in Q2 2019.
- Luther King Capital Management (LKCM) opened 33 new positions and closed 24 in Q2 2019.
- Luther King Capital Management (LKCM)'s portfolio value rose 4.8% quarter-over-quarter to $13.7B.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2019, filed 12 Aug 2019.